Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT06914401

Oxygenation Procedure for Obese Patients During Intubation in the Operating Room

Led by Clinique Pasteur · Updated on 2026-03-06

124

Participants Needed

5

Research Sites

88 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Obesity is a risk factor for difficult intubation, with an incidence of up to 15.5%, and difficult mask ventilation. Obesity also reduces the functional residual capacity (FRC) of the lungs, the main reservoir of oxygen during apnoea. Complications associated with induction and intubation in the operating room are more frequent in obese patients. Preoxygenation is a cornerstone in the management of patients at risk of desaturation during induction. The study aims to compare two oxygenation strategies , in obese patients. Oxygenation using a combination of NIV (Non Invasive Ventilation) and HFNO (High Flow Nasal Oxygen) compared with NIV alone in the operating room for induction of general anaesthesia with orotracheal intubation.

CONDITIONS

Official Title

Oxygenation Procedure for Obese Patients During Intubation in the Operating Room

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient requiring general anaesthesia with orotracheal intubation in the operating room
  • Obese patient (Body Mass Index , BMI 65 30kg/m2)
  • Patient affiliated to or benefiting from a social security scheme
  • Patient having signed the free and informed consent form.
Not Eligible

You will not qualify if you...

  • Haemodynamic instability
  • Intubation without laryngoscopy (fibroscope intubation) or nasotracheal intubation
  • Emergency surgery not allowing patient consent
  • Patient with a contraindication to NIV or OHD
  • Protected patients: Adults under guardianship, curatorship or other legal protection; deprived of liberty by judicial or administrative decision; pregnant, breast-feeding or parturient women; hospitalised without consent.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 5 locations

1

CHU Clermont Ferrand - Site Estaing

Clermont-Ferrand, France, 63100

Actively Recruiting

2

Clinique Honoré Cave

Montauban, France, 82000

Actively Recruiting

3

Hôpital Saint Eloi - CHU Montpellier

Montpellier, France, 34295

Actively Recruiting

4

Clinique Mutualiste La Sagesse

Rennes, France, 35000

Actively Recruiting

5

Clinique Pasteur

Toulouse, France, 31000

Actively Recruiting

Loading map...

Research Team

S

Ségolène MROZEK, MD, PhD

CONTACT

S

Stéphanie SAVY, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here